News on CML -Archives 2020-2021 -Chronic myeloid leukemia
Platelet, Hemoglobin Levels Related to COVID-19 Mortality in Hematologic Malignancies
December 30, 2021, Oncology Nurse Advisor
Regular Assessment of Patient-Reported Factors Related to QOL Recommended in Patients With CML
December 29, 2021, Oncology Nurse Advisor
Neutrophil Extracellular Traps Are Increased in Chronic Myeloid Leukemia and Are Differentially Affected by Tyrosine Kinase Inhibitors
December 27, 2021, PubMed
Communication, education key to optimal management of chronic myeloid leukemia
December 27, 2021, Healio
Combined GSTT1 Null, GSTM1 Null and XPD Lys/Lys Genetic Polymorphisms and Their Association with Increased Risk of Chronic Myeloid Leukemia
December 22, 2021, Dovepress
Death of Professor Michele Baccarani, 1942-2021
December 21, 2021, International CML Foundation
See also some videos of Professor Michele Baccarani
Adaptation Is Key to Advancing Care for Adult Patients With Leukemia
December 21, 2021, OncLive
Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients
December 21, 2021, PubMed
Doctor Shares CML Treatment Updates from ASH 2021 VIDEO
December 21, 2021, Patient Power
Durable humoral responses after the second anti-SARS-CoV-2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors
December 19, 2021, BJHaem
A Conversation with MSK’s Charles Sawyers: What’s Next for Precision Oncology
December 17,2021, Memorial Sloan Kettering Cancer center
Comparing Asciminib With Bosutinib in Patients With Chronic-Phase Chronic Myeloid Leukemia
December 17, 2021, DocWireNews
ACE-27 Score Has Prognostic Potential in Chronic Phase Chronic Myeloid Leukemia
December 14, 2021, Oncology Nurse Advisor
An Overview of Chronic Myeloid Leukemia (CML)
December 14, 2021, OncLive
ASH 2021 | Ascentage Pharma Releases Long-Term Clinical Data of Olverembatinib (HQP1351) in Oral Presentation Demonstrating Efficacy and Safety
December 14, 2021, PR Newswire
Can Dasatinib Dose Be Halved in Low-Risk CML?
December 14, 2021, MedPageToday
ASH 2021: New OPTIC Trial Analysis Shows Ponatinib is Effective in Chronic Myeloid Leukemia Patients VIDEO
December 14, 2021, CheckRare
Next Steps for Ponatinib VIDEO
December 14, 2021, CheckRare
Patients With Chronic-Phase CML Achieved Deeper, More Durable Molecular Responses With Asciminib Vs Bosutinib
December 13, 2021, CancerNetwork
Targeting TKI-resistant CML with LY3009120 and asciminib VIDEO
December 13, 2021, VJHemOnc – Video Journal of Hematological Oncology
Promising Activity Observed With Ponatinib Treatment in T315I-Mutated CP-CML
December 12, 2021, CancerNetwork
Seroconversion After COVID-19 Vaccination High in CML, Low in NHL
December 11, 2021, Cancer Therapy Advisor
Novartis Scemblix® demonstrates sustained response rate in 48-week follow-up in patients with chronic myeloid leukemia
December 11, 2021, GlobeNewswire
New Longer-term Efficacy, Safety Data of Asciminib in CML
December 11, 2021, Pharmacy Times
Low-Dose Dasatinib Could be Considered in Older Patients with CML
December 8, 2021, Docwirenews
Treatment of CML With Tyrosine Kinase Inhibitors Associated With Risk of Vascular Adverse Events
December 8, 2021, OncologyNurseAdvisor
CD44: a potential therapeutic target in chronic myeloid leukemia
December 5, 2021, PubMed
Eltrombopag for Managing Thrombocytopenia Associated With TKI Therapy in Patients With CML and Myelofibrosis
December 4, 2021, Practice Update
Managing Pregnancy in Patients With CML
December 3, 2021. Targeted Oncology
STAT5 inhibitor Pimozide as a probable therapeutic option in overcoming Ponatinib resistance in K562 leukemic cells
November 28, 2021, PubMed
Bowel Perforation Secondary to Ponatinib Treatment in a Chronic Myelogenous Leukemia Patient: A Case Report
November 27, 2021, PubMed
Ankle-Brachial Index, Cardiac Ankle Vascular Index May Indicate Risk of Cardiovascular AEs in Patients With CML Taking TKIs
November 23, 2021, Oncology Nurse Advisor
InsightRX’s Precision Medicine Technology to Help Improve Care for Patients Receiving Stem Cell Transplants
November 22, 2021, Bio-ITWorld
Ascentage Pharma's Olverembatinib Granted Orphan Designation by the European Commission for the Treatment of Chronic Myeloid Leukemia
November 21, 2021, yahoo! finance
Leukemia Stem Cells as a Potential Target to Achieve Therapy-Free Remission in Chronic Myeloid Leukemia
November 20, 2021, PubMed
UMass Cancer Center funds five UMass Chan research projects
November 17, 2021, UMass Chan Medical School
Activated naïve γδ T cells accelerate deep molecular response to BCR-ABL inhibitors in patients with chronic myeloid leukemia
November 16, 2021, Blood Cancer Journal
Age- and Gender-Independent Association of XRCC1 Arg399Gln Polymorphism with Chronic Myeloid Leukemia
November 16, 2021, DovePress
Factors That Impact HRQOL in Pediatric Patients With Chronic Myeloid Leukemia
November 16, 2021, Cancer Therapy Advisor
How the Study of Leukemias Inspired a Decades-Long Career
November 14, 2021, Cancer Network
8-Year-Old Boy Told Fractured Kneecap Was Causing Weight Loss, Vomiting Is Ultimately Diagnosed With Chronic Myeloid Leukemia
November 12, 2021, survivornet
Omacetaxine An Exciting Advance In Chronic Leukemia Care
November 11, 2021, Oncology Nursing News
Conference Will Highlight Strategic Treatment Delineation in AML, CML
November 9, 2021, Targeted Oncology
Debating Frontline Therapy in Chronic Myeloid Leukemia
September 7, 2021 Frontiers in Oncology
ASH 2021 | Ascentage Pharma to Present Three Studies of Olverembatinib (HQP1351), a Novel Drug Candidate for the Treatment of Drug-Resistant Leukemia, in Abstracts Including One Oral Report at ASH Annual Meeting
November 4, 2021, yahoo!
ASH 2021 | Ascentage Pharma to Present Three Studies of Olverembatinib (HQP1351), a Novel Drug Candidate for the Treatment of Drug-Resistant Leukemia, in Abstracts Including One Oral Report at ASH Annual Meeting
November 4, 2021, PR Newswire
Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors
November 4, 2021, PubMed
Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells
November 2, 2021, JCL Insight
A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML
November 2, 2021, PubMed
Petoskey mother of two battling rare leukemia, seeks bone marrow donor
November 2, 2021, News-Review
FDA Approves Scemblix for Pretreated CML in the Chronic Phase
October 29, 2021, Cure Today
Folic Acid-Appended Hydroxypropyl-β-Cyclodextrin Exhibits Potent Antitumor Activity in Chronic Myeloid Leukemia Cells via Autophagic Cell Death
October 28, 2021, PubMed
Pat Garcia-Gonzalez Receives Outstanding Contribution to Cancer Control Award by UICC
October 26, 2021, The Max Foundation
Comparison of Generic and Branded Imatinib for Patients With Chronic Myeloid Leukemia
October 26, 2021, Hematology Advisor
Assessment of Oral Chemotherapy Nonadherence in Chronic Myeloid Leukemia Patients Using Brief Measures in Community Cancer Clinics: A Pilot Study
October 21, 2021, PubMed
Algorithm Assesses Risk of Major Adverse Cardiovascular Events in TKI-Treated CML
October 21, 2021, Oncology Nurse Advisor
Gleevec: A 'Miracle Drug' for Some Patients With Chronic Myeloid Leukemia
October 18, 2021, CureToday
Outcome of COVID-19 in patients with chronic myeloid leukemia: A single centre UK experience
December 15, 2021, Journal of Medical Virology
Just 44% of people with blood cancer invited for potentially lifesaving third vaccine dose
October 15, 2021, Blood Cancer UK
Utilization Patterns Explain Nonadherence to Treatment for Multiple Myeloma, CML, Some Metastatic Cancers
October 8, 2021, Oncology Nurse Advisor
Review Outlines Progress on GE-Based Biomarkers for CML
October 7, 2021, AJMC
Caring for your mental health after a new cancer diagnosis
October 6, 2021, MD Anderson Cancer Center
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: lessons from the CounterCovid - imatinib - study
October 5, 2021, ASCPT
Patient Characteristics Impact Effectiveness of TKIs in CML and AEs Experienced
October 1, 2021, AJMC
New cancer ‘inhibitor’ could lead to improved treatment options
September 30, 2021, Drug Discovery World
Dose-Reduction Strategy Maintains Efficacy, Averts Serious Events in CML
September 28, 2021, OncLive
Patient Perspective a Missing Component of Studies on Tyrosine Kinase Inhibitor Therapy Adherence
September 27, 2021, Oncology Nurse Advisor
New insight into the catalytic -dependent and -independent roles of METTL3 in sustaining aberrant translation in chronic myeloid leukemia
September 24, 2021, Nature
Mesa couple bikes in honor of son who survived cancer
September 21, 2021, ABC15
Zeldin says he's in remission after treatment for leukemia
September 19, 2021, The Hill
Review of the Cardiovascular Risks of TKI Therapy for Chronic Myeloid Leukemia
September 15, 2021, Oncology Nurse Advisor
Comorbidities Don’t Hinder Dasatinib’s Activity in Chronic Phase Chronic Myeloid Leukemia
September 13, 2021, Cancer Therapy Advisor
Dose-Optimization of Ponatinib in Patients With Resistant/Intolerant Chronic-Phase Chronic Myeloid Leukemia
September 10, 2021, Hematology Advisor
Tyrosine kinase inhibitor-associated cardiovascular adverse events in chronic myeloid leukemia
September 9, 2021, Docwirenews
Dr. Cortes on Emerging Therapies in CML
September 8, 2021, OncLive
Tasigna Lawsuits Against Novartis
September 7, 2021, Lawsuit Information Center Blog
Current evidence on the efficacy and safety of generic imatinib in CML and the impact of generics on health care costs
September 3, 2021, Blood Advances
Pulmonary Hypertension Risk Increases With Tyrosine Kinase Inhibitor Use
September 2, 2021, Oncology Nirse Advisor
FDA Accelerates Review of Asciminib for Patients with Chronic Myeloid Leukemia
August 27, 2021, Pharmacy Times
Tyrosine kinase inhibitor and vascular adverse events in chronic myeloid leukemia patients: a population-based, propensity score-matched cohort study
August 27, 2021, The Oncologist
FDA Grants Priority Review to Asciminib for Chronic Myeloid Leukemia
August 25, 2021, OncLive
Expert Series: Dr Ilaria Pagani talks treatment-free remission in CML
August 25, 2021, Leukaemia Foundation
Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors?
August 18, 2021, Leukemia
A Phase 3, Open-Label, Randomized Study of Asciminib, a STAMP Inhibitor, vs Bosutinib in CML After ≥2 Prior TKIs
August 18, 2021 ASH Publications - Blood
Professor Jörg Hasford (1950 – 2021)
See more about Professor Jörg Hasford
August 16, 2021, iCMLf
Researchers Seek to Assess Monthly Adherence to Oral Chemotherapy Agents in Chronic Myeloid Leukemia
August 16, 2021, Oncology Nurse Advisor
One in a Million: 15-year-old George County boy diagnosed with two types of leukemia
August 5, 2021, WLOX
New-Generation BCR-ABL TKIs Linked to Increased Risk of Hepatotoxicity in Patients With Chronic Myeloid Leukemia
August 4, 2021, Oncology Nurse Advisor
DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model
July 29, 2021, MDPI.com
Long-term outcome of tyrosine kinase inhibitor treatment in children and adolescents with newly diagnosed chronic myeloid leukemia in chronic phase
July 22, 2021, Chinese Medical Journal
3 existing drugs fight coronavirus with ‘almost 100%’ success in Jerusalem lab
July 20, 2021, The Times of Israel
Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors
July 20, 2021, PubMed
Cardiovascular events and atherogenic lipid profile in chronic myeloid leukemia patients treated with nilotinib versus imatinib
July 20, 2021, PubMed
Arterial hypertension assessment in a population with chronic myeloid leukemia
July 19, 2021, PubMed
Profiles of NK cell subsets are associated with successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia and changes following interferon treatment
July 19, 2021, PubMed
Jabbour on Tailoring Treatment With TKIs in CML and Ph+ ALL
July 19, 2021, OncLIve
Chemical Exposure and Myeloid Malignancies: More Research Is Needed
July 15, 2021, CURE
Alterations in Sialylation Patterns are Significantly Associated with Imatinib Mesylate Resistance in Chronic Myeloid Leukemia
July 15, 2021, PubMed
Vaccine effectiveness for people with chronic myeloid leukaemia (CML)
July 14, 2021, Blood Cancer UK
Pregnancy blood test 'possibly saved my life' after leukaemia diagnosis
July 14, 2021, BBC News
COVID-19 in chronic myeloid leukemia patients in Latin America
July 13, 2021, Taylor & Francis Online
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
July 12, 2021, NCBI
Therapeutic Drug Monitoring Improved Incidence of Pleural Effusion With Dasatinib for CP-CML
July 12, 2021, Oncology Nurse Advisor
Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: A review
July 9, 2021, Survey of Ophthamology
Nilotinib-induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study
July 9, 2021, MDLinx
Role of Lysophospholipid Metabolism in Chronic Myelogenous Leukemia Stem Cells
July 8, 2021, MDPI
VIDEO: Ponatinib dose-optimization beneficial for CML despite cardiac toxicity
July 7, 2021, Healio
Registry Data Support Use of Ponatinib in CML, Ph+ ALL Resistant or Intolerant to Tyrosine Kinase Inhibitors
July 5, 2021, Oncology Nurse Advisor
Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up
July 1, 2021, PubMed
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients
June 30, 2021, BJHAem
What to know about chronic myeloid leukemia in children
June 29, 2021, MedicalNewsToday
Friendly Competition Fosters Progress in Hematologic Malignancies
June 28, 2021, Cancer Network
Substudy to Assess CML Patients’ Perspectives on Treatment-Free Remission
June 25, 2021, Oncology Nurse Advisor
Understanding and Monitoring Chronic Myeloid Leukemia Blast Crisis: How to Better Manage Patients
June 23, 2021, DovePress
VIDEO: High dose ponatinib benefits patients with chronic myeloid leukemia
June 22, 2021, Healio
TKI Selection in CML: Clinical, Economic Burden and Long-term Outcomes
June 18, 2021, AJMC
Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Safe, Successful, Even Outside Clinical Trials
June 16, 2021, Oncology Nurse Advisor
Parents of 6-year-old cancer patient plead for bone marrow donor
June 12, 2021, WBAY.com
The loss of life expectancy in patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989-2018
June 11, 2021, EHA Library
CML: COVID-19 May Be Fatal in More Than 5% of Patients
June 11, 2021, Cancer Therapy Advisor
Treatment for CML Is Unclear in Later Stages of Disease
June 11, 2021, AJMC
Remembering ‘Batman’ Actor Adam West, Who Passed 4 Years Ago to Leukemia: One of the Most Iconic Voices of Our Time
June 9, 2021, survivornet
Epidemiological, therapeutic, cytogenetic, and molecular profile of chronic myeloid leukemia at the national reference university hospital of N’Djamena from 2010-2020, Chad
June 8, 2021, World Journal of Advanced Research and Reviews
Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia
June 7, 2021, Dovepress
Potatinib Dosing Regimen Demonstrates Improved Responses, Survival in Patients With CP-CML
June 5, 2021, Oncology Learning Network
Response-Based Ponatinib Dosing Appears Effective in Chronic Phase Chronic Myeloid Leukemia
June 5, 2021, Cancer Therapy Advisor
Dr Christopher Arendt on OPTIC Findings for Dose Optimization of Ponatinib in Patients With CP-CML
June 5, 2021, AJMC
Cognitive Behavioral Therapy Improved Tyrosine Kinase Inhibitor-Related Fatigue in Patients With Chronic Myeloid Leukemia
June 3, 2021, Oncology Nurse Advisor
Chronic Myeloid Leukemia: What Your Patients Need to Know
June 2, 2021, Cancer Therapy Advisor
Later Lines of Therapy Increase Humanistic and Economic Burden in CML
June 1, 2021, AJMC
Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy
May 26, 2021, Frontiers in Oncology
Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations
May 2020, National Library of Medicine
How Intermittent Fasting Affects Patients Receiving Tyrosine Kinase Inhibitors for CML
May 25, 2021, Cancer Therapy Advisor
'Live in the moment': Rachel Purcell on making a life she is happy with after cancer shock
May 23, 2021, Irish Examiner
Navigating cancer diagnosis and treatment
May 18, 2021, RNZ
Positive Primary Analysis from the Phase 2 OPTIC Study of Ponatinib (Iclusig®) in Chronic Phase-Chronic Myeloid Leukemia (CP-CML) to be Presented at the 2021 ASCO Annual Meeting
May 20, 2021, businesswire
Combo Therapy for Philadelphia Chromosome-Positive ALL Shows Positive Results
May 20, 2021, Clinical Omics
Greencastle-Antrim High School junior gets new lease on life with stem cell transplant
May 19, 2021, Echo-Pilot
Arnold softball player staying strong in battle with cancer
May 19, 2021, Local sports
Models of care for chronic myeloid leukemia patients during the COVID‐19 pandemic in the United Kingdom: Changes in patient attitudes to remote consultations and future implications
May 14, 2021, eJHaem
'Game-changer' cancer drug celebrates 20 years. Gleevec turned a death sentence into a chronic disease for many.
Many 10, 2021, USA Today
OHSU marks 20 years of life-saving cancer drug
May 7, 2021, KGW8
Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias
May 5, 2021, MDLinx
Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience
April 2021, PubMed
Asciminib in chronic myeloid leukemia: many questions still remain to be answered
April 29, 2021, Blood Journal Cancer
Single dose of Pfizer-BioNTech COVID-19 vaccine induces immunity in CML patients
April 25, 2021, News Medical
Asciminib for the Treatment of Patients With Chronic Myeloid Leukemia
April 2021, Clinical Advances in Hematology and Oncology
Chronic myeloid leukemia: What you need to know
April 15, 2021, Medical News Today
Treatment options by phase for chronic myeloid leukemia
April 15, 2021, Medical News Today
Scientists identify potential drug candidates for deadly pediatric leukemia
April 14, 2021, Medical Xpress
Updated Analysis of Data Demonstrates Efficacy of TFR in Chronic Myeloid Leukemia in Chronic Phase
April 9. 2021, Oncology Nurse Advisor
Scientists discover 'jumping' genes that can protect against blood cancers
April 8, 2021, Science Daily
Chronic Myeloid Leukemia Becomes A Category of Diseases
April 8, 2021, PatientWorthy
Medolife Rx Announces Positive Pre-Clinical Results Showing Up to 95 Percent Cancer Cell Apoptosis with Introduction of Lead Cancer Drug Candidate
April 8, 2021, Yahoo!finance
Dasatinib, Nilotinib Effective Second-Line Therapy for Chronic Myeloid Leukemia
April 7, 2021, Hematology Advisor
In Memoriam of Minella López
April 7, 2011, CML Advocates Network
Hepatitis B Flare Trends Identified for Bcr-Abl TKI Treatment
April 7, 2021, HCOLive
BCR-ABL1 Kinetics Associated With Long-Term TFR Status in Patients With Chronic Myeloid Leukemia
March 31, 2021, Oncology Nurse Advisor
Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia
March 27, 2021, PubMed
Case Study Shows Potential Protective Effect of TKI Therapy for Chronic Myeloid Leukemia
March 26, 2021, Oncology Nurse Advisor
Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia
March 25, 2020, Cancer Connect
Op-Ed: Blood Cancer Patients Need More COVID Vax Answers
March 24, 2011, Medpage Today
Molecular Response Maintained With Intermittent Tyrosine Kinase Inhibitor Regimen in Patients With CML
March 10, 2021, Oncology Nurse Advisor
Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
March 9, 2021, ClinicalTrials.gov
Ultrasound arterial anomalies in patients exposed to nilotinib therapy for chronic myeloid leukemia
March 6, 2021, PubMed
Better MRD Testing May Predict Relapse in Leukemia Subtypes
March 2, 2021, Oncology Nursing News
14-year-old Leukemia Patient Desperately In Need of Bone Marrow Transplant Rallies 11,000 to Register; Why It’s More Difficult to Find a Match for Black People
March 1, 2021, Survivornet
A mother leads the social media charge to register bone marrow donors and help her son beat cancer
March 1, 2021, WCVB5
Treatment Advances Transform CML Into Chronic Disease
February 27, 2021, Cure
People with Cancer Urged to Get the COVID-19 Vaccine
February 26, 2021, Patient Power
Schiller Talks TKIs, Treatment Discontinuation, and Transplant in CML
February 23, 2021, OncLive
Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group
February 22, 2021, J-Stage
Knocking Out Chronic Myeloid Leukemia with Precision
February 22, 2021, Cure
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study
February 19, 2021, MDLinx
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study
February 16, 2021, Cancer Medicine
Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI
February 15, 2021, Leukemia
Dr Atallah Assesses Outcomes Following the Discontinuation TKIs in CML
February 15,2021, Oncology Learning Network
Hem/Onc Roundup: Dr. Cortes Discusses Ponatinib for CML; Plus, Liquid Biopsy for Pancreatic Cancer
February 12, 2021, docwirenews
Chronic love: Dating, sex and living with illness
February 12, 2021, Healthing.ca
FDA Grants Breakthrough Therapy Designation to Asciminib for 2 CML Indications
February 10,2021, Cancer Network
Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor for Patients with Chronic Myeloid Leukemia
February 10,2021, DovePress
FDA Grants Breakthrough Therapy Designations to Asciminib for CML
February 9, 2021, OncLive
FDA Grants 2 Breakthrough Therapy Designations to Asciminib in Ph+ CML
February 8, 2021, Targeted Therapy
TKI Discontinuation Found to Benefit PROs in CML, Study Says
February 6, 2021, AJMC
What to know about childhood leukemia
February 5, 2021, Medical News Today
Dr. Cortes Discusses Approval of Ponatinib for Adults with Chronic-phase CML
February 5, 2021, docwirenews
The Importance of Building Trust in COVID-19 Vaccines
February 4, 2021, Patient Power
Research of the Philadelphia Chromosome in Chronic Myeloid Leukemia: Diagnostic and Prognostic Interests
February 4, 2021, IntechOpen
Leukemia treatment pioneer dies of COVID-19
February 4, 2021, WDBJ7
Activity of First-in-Class STAMP Inhibitor in T315I-Mutated CML
February 1, 2021, JNCCN360
New Drug for Chronic Myeloid Leukemia Might Stimulate the Market
January 2021, Clinical Cancer Research
Wallaceburg-born woman needs your help in battling blood cancer
January 29, 2021, The Courier Press
TP53 Modifier Impresses in Early MDS/AML Study
January 26, 2021, Medpage Today
Two antiviral enzymes transform pre-leukemia stem cells into leukemia
January 26, 2021, Medical Xpress
Anti-emetic drug offers a promising approach to treat chronic myeloid leukemia
Janvier 26, 2021, News Medical
Myeloid immune cells in the blood tied to severe COVID-19
January 26, 2021, Medical Xpress
Metoclopramide inhibits proliferation of leukemia stem cells
January 27, 2021, Medical Xpress
Leukemia Survival Likely Not Affected by Diabetes, Hemoglobin A1C
January 21, 2021, AJMC
Target of new cancer treatment valid for breast as well as blood cancers: study
January 20, 2021, University of Alberta
Living with blood cancer and pets
January 20, 2021, Leukemia Foundation
What cancer patients should know about getting the COVID-19 vaccine at MD Anderson
January 19, 2021, Md Anderson Cancer Center
Likely Determinants of Successful TKI Treatment Stoppage Identified in CML
January 16, 2021, AJMC
Why Dr Morrison pays attention to his vitamin C intake
January 15, 2021, Leukaemia Foundation
Real-World Treatment Patterns, HCRU in Patients With CML Achieving Later Lines of Therapy
January 14, 2021, Journal of Clinical Pathways
High-grade B-cell lymphoma developed during the treatment of chronic myeloid leukemia with bosutinib
January 13, 2021, PubMed
UM171: the molecule that keeps on giving
January 12, 2021, Udem Nouvelles
Dr.Jeff Lipton: In case you're wondering if you should get the COVID vaccine, the answer is YES. (VIDEO)
January 9, 2021, The Canadian CML Network
Iclusig receives FDA sNDA approval for adult patients with resistant or intolerant chronic-phase CML
January 8, 2021, The Cancer Letter
Failure to initiate TKIs linked to higher inpatient costs for older patients with CML
January 7, 2021, Healio
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom?
December 2000, Haematologica
Xspray Pharma : HyNap-Nilo receives FDA Orphan Drug Designation for the treatment of Chronic Myeloid Leukemia
December 30, 2020, MarketScreener
New Treatment Options for Chronic Myelogenous Leukemia
Decembre 29, 2020, Patient Power
Iclusig Approved for Resistant or Intolerant Chronic-Phase CML
December 22, 2020, MPR
Predictors of tyrosine kinase inhibitor (TKI) adherence trajectories in chronic myeloid leukemia (CML) patients
December 21, 2020, Fred Hutch
Managing the “Knowledge Explosion” a Key Challenge of Precision Oncology
December 20, 2020, AJMC
FDA Approves Ponatinib To Treat Adult Patients with Resistant/Intolerant Chronic-Phase CML
December 18, 2020, Cancer Network
FDA Issues Emergency Use Authorization to Moderna COVID-19 Vaccine
December 18, 2020, Cancer Network
Dr. Cortes on Navigating Among Frontline TKIs in the CML Paradigm
December 16, 2020, OncLive VIDEO
Dr. Jabbour on the ASCEMBL Data With Asciminib in Chronic-Phase CML
December 16, 2020, OncLive VIDEO
Dr. Sweet on Treatment Selection With TKIs in CML
December 15, 2020, OncLive VIDEO
Dr. Hobbs on Managing Ponatinib-Associated Toxicities in CML
December 15, 2020, OncLive VIDEO
Stopping TKI Treatment Is Safe, Improves Quality of Life for Some with CML
December 15, 2020, National Cancer Institute
Coronavirus: What is it and how can I protect myself?
December 15, 2020, Mayo Clinic
New TKI Therapy Shows Promise for Patients with Recurrent CML
Decembre 14, 2020, Patient Power
FDA Grants Emergency Use Authorization to First COVID-19 Vaccine
December 11, 2020, Cancer Network
Clinical Challenges: Discontinuing TKIs in Chronic Myeloid Leukemia
December 11, 2020, Medpage Today
Vitamin D and COVID 19: The Evidence for Prevention and Treatment of Coronavirus (SARS CoV 2)
December 10, 2020, MedCram - Medical Lectures Explained CLEARLY
Andreas Hochhaus, MD, Talks About the ASCEMBL Trial, Eliminating LSCs in CML
December 10, 2020, Oncology Learning Network
Abdul-Jabbar reveals past prostate cancer diagnosis in essay
December 10, 2020, Wreg Memphis
Novartis eyes 2021 regulatory submissions for ‘STAMP’ inhibitor asciminib
December 9, 2020, PMLive
AI-Based Model Made Optimal Selections of Frontline TKI Therapy in CML
December 9, 2020, Oncology Nurse Advisor
ASH 2020: Study Shows Asciminib to be Safe and Effective for Hard-to-Treat
December 8, 2020. Onco’Zine
Understanding the Use of Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase CML
December 8, 2020, Pharmacy Times
Novartis investigational STAMP inhibitor asciminib (ABL001) shows superior MMR rate to Bosulif®* in chronic myeloid leukemia trial
December 8, 2020, PR Newswire
Ponatinib Demonstrates Efficacy Over Time for Patients With CP-CML After Prior TKI Failure
December 7, 2020, Targeted Oncology
New cancer drugs lead to life-threatening financial choices
December 7, 2020, Fred Hutch
Asciminib Emerges as a Potential Treatment Alternative in Heavily Pretreated CML
December 6, 2020, OncLive
Asciminib Represents New Safe and Effective Treatment Option for Heavily Pretreated CML
December 6, 2020, Targeted Oncology
Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
December 4, 2020, Hematology Advisor
How to manage CML patients with comorbidities
December 4, 2020, ASH 2020 Education program
Targeting persisting stem cells in search for a novel CML treatment VIDEO
December 3, 2020, VJHemOnc – Video Journal of Hematological Oncology
TKI Discontinuation Associated With Improved PROs in CML
December 3, 2020, Journal of Clinical Pathways
TKI discontinuation safe for certain patients with chronic myeloid leukemia
December 3, 2020, Healio
Targeting of the Alox12-12-HETE in Blast Crisis Chronic Myeloid Leukemia Inhibits Leukemia Stem/Progenitor Cell Function
December 3, 2020, PubMed
Systematic analysis reveals a lncRNA-miRNA-mRNA network associated with dasatinib resistance in chronic myeloid leukemia
December 2, 2020, PubMed
Elevated stress hormone levels could reawaken dormant cancer cells, study finds
December 2, 2020, STAT news
Why is it critical to achieve a deep molecular response in chronic myeloid leukemia?
December 2020, Haematologica
Clinical Trials Are Underway on Novel Approaches to CML-Resistant BCR-ABL1 Inhibitors
November 27, 2020, Targeted Oncology
The coronavirus vaccine: what you need to know
November 25, 2020, Blood Cancer UK
New data at ASH to reinforce breadth of Novartis hematology portfolio across multiple blood cancers and serious hematologic diseases
November 19, 2020, GlobalNewsWire
The LEukemia Artificial Intelligence Program (LEAP) in Chronic Myeloid Leukemia in Chronic Phase: A Model to Improve Patient Outcomes
November 12, 2020, American Journal of Hematology
TKI Discontinuation Safe in CML, Improved PROs
November 12, 2020, MedpageToday
Handling challenging questions in the management of chronic myeloid leukemia: when is it safe to stop tyrosine kinase inhibitors?
November 10, 2020, Blood Advances
Scientists discover safeguard that protects blood's 'Fountain of Youth'
November 9, 2020, Medical Xpress
The costs of treating and not treating patients with chronic myeloid leukemia with tyrosine kinase inhibitors among Medicare patients in the United States
November 4, 2020, MDLinx
Dr. Schiffer on Factors to Consider for TKI Discontinuation in CML
November 2, 2020, OncLive
The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase
November 2020, Leukemia Research
Standardizing Optimal Diagnostic Procedures and Monitoring Strategies in CML
October 29, 2020, OncLive
Schiffer Spotlights Potential for TKI Discontinuation in Select Patients With CML
October 28, 2020, OncLive
New leukemia treatment targets specific protein in blood, prevents cancer from developing
October 24, 2020, StudyFinds
Repurposing and Combining Drugs – An Effective Cancer Treatment Strategy
October 23, 2020, Technology Networks
Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors
October 22, 2020, PubMed
Priority Review Granted to Ascentage Pharma's New Drug Application for Olverembatinib (HQP1351), the First Third-Generation BCR-ABL Inhibitor in China
October 21, 2020, Ascentage Pharma
British Society for Haematology Guideline Update for the Diagnosis and Management of Chronic Myeloid Leukemia
October 21, 2020, Cancer Therapy Advisor
Doctor Explains CML Definition, Diagnosis and Prognosis
October 16, 2020, Patient Power
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients?
October 15, 2020, Karger.com
Case Report: IgG multiple myeloma and chronic myeloid leukemia in a single patient
October 13, 2020, Docwirenews
Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia
October 12, 2020, PubMed
Patients With CML Continue to Be Prescribed Costly Second-Gen TKIs
October 9, 2020, Cancer Therapy Advisor
Emerging Therapies in CML Undergo Investigation in Chronic-Phase Illness
October 7, 2020, Targeted Oncology
The Nobel Prize in Chemistry 2020 was awarded jointly to Emmanuelle Charpentier and Jennifer A. Doudna "for the development of a method for genome editing."
October 7, 2020, Nobel Prize
Efficacy and safety profile of generic imatinib in patients with newly diagnosed chronic myeloid leukemia-chronic phase: sharing experience of a hemato-oncology center from eastern India
October 6, 2020, PubMed
Economic Burden of CML Treatment in the US: Before and After the Availability of Generic Imatinib
October 3, 2020, Journal of Clinical Pathways
Can vitamin D protect against the coronavirus disease 2019 (COVID-19)?
October 2, 2020, Mayo Clinic
NMR insights set stage for next-gen targeted cancer therapies for adults and children
October 2, 2020, Mirage
CytoGPS: A large-scale karyotype analysis of CML data
October 2, 2020, Cancer Genetics
Evaluation of the plasma concentration of ponatinib in a chronic myeloid leukaemia patient with ponatinib intolerance
September 28, 2020, PubMed
New technology causes body to fight cancer at full strength
September 24. 2020, Mirage
World CML Day webinar with Professor Tim Hughes
September 22, 2020, Leukaemia Foundation - Blood Cancer Information
New Path for Preventing Chronic Myelogenous Leukemia Relapse Discovered
September 21, 2020, GEN – Genetic Engineering & Biotechnology News
Major BCR-ABL1 Transcript Type Linked to Better Imatinib Response in CML
September 16, 2020, Oncology Learning Network
Ponatinib starting dose may be linked to efficacy, safety in chronic-phase CML
September 15, 2020, Healio
Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches
September 14, 2020, PNAS
Pulmonary Embolism in People With Blood Cancer
September 12, 2020, Very Well Health
Israeli researcher recommends psychological treatment for CML patients
September 10, 2020, The Jerusalem Post
Study Finds Treatment-Free Remission Not Impaired by Low-Dose TKIs for Patients with CML
September 9, 2020, Cancer Network
Ponatinib and Other CML Tyrosine Kinase Inhibitors in Thrombosis
September 8, 2020, International Journal of Molecular Sciences
Checkpoint kinase‑1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair
September 7, 2020, Spandidos Publications
Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients
September 4, 2020, MDPI
CML Costs Exceed Those of Other Hematologic Malignancies
September 1, 2020, Journal of Clinical Pathways
Novartis Push To Expand Cancer Arsenal Gets Trial Win Against Pfizer Bosulif
August 28, 2020, Medical Dialogues
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
August 27, 2020, Journal of Oncology Pharmacy Pratice
Novartis reports positive data of asciminib in ASCEMBL trial
August 27, 2020, Clinical Trials Arena
Novartis investigational novel STAMP inhibitor asciminib (ABL001) meets primary endpoint of Phase III chronic myeloid leukemia study
August 26, 2020, PipelineReview.com
New ultra-long circulating nanoparticle developed for chronic myeloid leukemia
August 24, 2020, Phys.org
Insulin: too much of a good thing is bad
August 21, 2020, BMC Medicine
The impact of time to response to treatment on the outcomes of patients with accelerated-phase chronic myeloid leukemia (CML)
August 20, 2020, Leukemia & Lymphoma Society
Leukemia cells simply ‘starve’ thanks to a special diet
August 18, 2020, Innovation Origins
Caring For Cancer Patients In Ethiopia Through Treatment And One-on-One
August 18, 2020, Africa.com
Chronic Myeloid Leukemia: Futuristic Views VIDEO
August 7, 2020, Manage Health Foundation MHF
CRISPR/Cas9 technology abolishes the BCR/ABL1 oncogene effect in chronic myeloid leukemia and restores normal hematopoiesis
August 5, 2020, BioRxiv
Trend in TKI Use, Adherence, and Switching Patterns in Patients With CML: Before and After the Availability of Generic Imatinib
August 2020, Journal of Clinical Pathways
Care Delivery and Collaboration in the Real World
August 2020, Journal of Clinical Pathways
Terns out-licenses BCR-ABL inhibitor for CML to Hansoh to accelerate entry to clinic
July 30, 2020, Bio World
iCMLf Conversations on CML and COVID-19 - Presentations available
July 2020, iCMLf
Trial Data Highlight Safety and Efficacy of Bosutinib for Chronic-Phase CML
July 21, 2020, Oncology Learning Network
Michael Mauro, MD, Talks ELN/NCCN Recommendations for Patients With CML
July 18, 2020, Oncology Learning Network
Chronic Myeloid Leukemia - Clinical Practice Guideline
July 2020, Alberta Health Service
Resistant Chronic Myeloid Leukemia: Starting Over Again
July 2020, Conquer the patient voice
Leukaemia Foundation Australia has a new website
July 2020, Leukemia Foundation
Dr. Brian Druker - Knight Cancer Institute at Oregon Health & Science University director named winner of Watanabe Prize, will deliver keynote address at virtual 2020 Indiana CTSI Annual Meeting
July 2020, Indiana CTSI
Surrogate Markers for Treatment-Free Remission in Patients With Chronic Myeloid Leukemia
July 15, 2020, Clinical Lymphoma & Myeloma & Leukemia
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients
July 14, 2020, PubMed
Coronavirus vaccine: will it help people with blood cancer?
July 13, 2020, Blood Cancer UK
One Sure Sign You've Already Had Coronavirus, Says Dr. Fauci
July 13, 2020, Yahoo! Life
Kareem Abdul-Jabbar's Life with Myeloid Leukemia: Facts about the NBA Legend's Cancer Battle
July 10, 2020, AmoMama
Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study
July 8, 2020, Leukemia
Ehab L. Atallah, MD, on Heterogeneity in CML Treatment: Focus on Monitoring Response
July 7, 2020, JNCCN360
“When Blood Breaks Down”: It Can Break Your Heart
July 2, 2020, The Health Care Blog
Family of toddler with rare blood cancer searching for bone marrow donor
July 2, 2020, KSL.com
Fatigue In Chronic Myeloid Leukemia Patients On Tyrosine Kinase Inhibitor Therapy: Predictors And The Relationship With Physical Activity
June 30, 2020, Haematologica
Does COVID Mess With the Menstrual Cycle?
June 29, 2020, Medpage Today
The EUTOS Long-Term Survival (ELTS) Score Is Superior to the Sokal Score for Predicting Survival in Chronic Myeloid Leukemia
June 29, 2020, PubMed
$1.62 million for rare cancer research
June 29, 2020, Mirage
Managing Patients With Myeloid Malignancies During and After the Global COVID-19 Pandemic
June 24, 2020, Targeted Oncology
Worse Blood Cancer Outcomes in Hispanics
June 24, 2020, Medpage Today
Bosutinib for Pretreated Patients With Chronic Phase Chronic Myeloid Leukemia: Primary Results of the Phase 4 BYOND Study
June 22, 2020, PubMed
Asciminib Well-Tolerated, Active in Heavily Pretreated Ph+ CML
June 22, 2020, Oncology Learning Network
Study Finds Hispanics Diagnosed with Blood Cancers at Younger Age
June 22,2020, Cancer Network
Chronic myelogenous leukemia presenting as central retinal vein occlusion.
June 22, 2020, Taylor and Francis Online
Disparities Seen in Hematologic Cancer Incidence and Survival for Hispanic Patients in Texas
June 22,2020, Targeted Oncology
Jorge E. Cortes, MD, on Chronic Phase CML: Comparing Three Starting Doses of Ponatinib VIDEO
June 11-21, 2020, The ASCO Post
Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey
June 18, 2020, Leukemia
Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances TEMP
June 19, 2020, Oncology nurse advisor
Ascentage Pharma Submits Its First New Drug Application to National Medical Products Administration, for HQP1351, the First Third-Generation BCR-ABL Inhibitor in China
June 18, 2020, Olean Times Herald
Safe Travel Tips for Patients with Cancer
June 17, 2020, Cure
Low-Dose TKIs Before Therapy Cessation Leave Treatment-Free Remission Rates Unscathed in CML
June 15, 2020, Oncology Learning Network
AACR Academy names president-elect
June 14, 2020, HemOncToday
Study Provides Support for TKI Discontinuation in Some Patients With CML
June 12, 2020, Cancer Therapy Advisor
Increased tumor burden in Chronic Myeloid Leukemia patients after 36 months of imatinib discontinuation
June 9, 2020, Blood
Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study
July 8, 2020, Leukemia
Updated Results Show Ongoing Treatment-Free Remission in CML Trial
June 6, 2020, Cancer Network
“I was diagnosed with CML then found out I was pregnant”
June 4, 2020, Leukaemia Foundation
Highlights of Current Research on Leukemia, MDS, and Allotransplant
June 4, 2020, Pharmacy Times
OncMadness 2020: Meet the Winners!
June 3, 2020, MedpageToday
Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia
June 2, 2020, Frontiers in Oncology
Korean Study Identifies Benefits of Combining Metformin With Nilotinib in CML
June 2, 2020, JNCCN360
Advance on the Effect of Autophagy on the Survival of Chronic Myeloid Leukemia Cells
June, 2020, PubMed
Combined inhibition of MDM2 and BCR-ABL1 tyrosine kinase targets chronic myeloid leukemia stem/progenitor cells in a murine model
May 2020, Haematologica 2020 Volume 105(5):1274-1284
Nilotinib appears safe and affects biomarkers in Alzheimer's disease clinical trial
May 29, 2020, Medical Xpress
Pregnancy outcomes in patients treated with bosutinib
May 29, 2020, PubMed
Minimal Residual Disease Status Appears to Correlate With Patient-Centered Outcomes in Those With Hematological Malignancies
May 29, 2020, ajmc
Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course
May 28, 2020, Physician’s Weekly
Long-term Survival Increasing in Patients With Hematologic Malignancies
May 28, 2020, ajmc
Low-dose Tyrosine Kinase Inhibitors Before Treatment Discontinuation Do Not Impair Treatment-Free Remission in Chronic Myeloid Leukemia Patients: Results of a Retrospective Study
May 27, 2020, PubMed
Moving on from 2013 to 2020 European LeukemiaNet recommendations for treating chronic myeloid leukemia: what has changed over the 7 years?
May 26, 2020, Taylor & Francis Online
'So if dying isn't enough of a motivation, what is?'
May 26, 2020, Healthing.ca
Treatment-free Remission in Chronic Myeloid Leukemia: The Patient Perspective and Areas of Unmet Needs
May 26, 2020, PubMed
Bosutinib in patients with chronic phase chronic myeloid leukemia intolerant to prior tyrosine kinase inhibitors: Analyses from the BYOND study
May 25, 2020, Journal of Clinical Oncology
The effect of stomach acid suppressants on the safety and effectiveness of dasatinib in patients with chronic myeloid leukemia (CML)
May 23, 2020, Medivizor
An Expert Opinion: Interferon and CML during the COVID-19 Pandemic
May 2020, iCMLf
Drugs for Chronic Myeloid Leukemia Arrive in PNG (Papua New Guinea)
May 22, 2020, Post-Courier
COVID-19 and CML: Frequently Asked Questions *** must be seen ***
May 21, 2020, American Society of Hematology
Poor tolerability to ponatinib in Indian CML patients
May 7, 2020, Blood advances
New combination treatment may overcome drug resistance in blood cancers
May 19, 2020, The University of British Columbia
COVID-19 in persons with chronic myeloid leukaemia
May 18, 2020, Leukemia
Delhi AIIMS tests popular cancer drug to see if it can prevent mild Covid from getting severe
May 16, 2020, The Print
Could Interferon Drugs Help Fight COVID-19?
May 15, 2020, WebMd
NGS Preferable for Detecting Certain Mutations in Patients With CML
May 14, 2020, Oncology Learning Network
Possible Predictors of Treatment-Free Remission in Patients with CML
May 13, 2020, Cancer Network
Imatinib as Potential Tyrosine Kinase Inhibitor to Treat Sickle Cell Disease
May 12, 2020, Hematology Advisor
A Case of Long-Term Dasatinib-Induced Proteinuria and Glomerular Injury
May 9, 2020, PubMed
Switch From Imatinib to Dasatinib May Benefit Certain Patients With CML-CP
May 7, 2020, Oncology Learning Network
Treatment-free remission in patients with chronic myeloid leukaemia
May 6, 2020, Nature
Onc Daily: 80K Missed Cancer Diagnoses, Generic Imatinib
May 6, 2020, Medscape
FDA Grants Orphan Drug Designation to HQP1351 for Chronic Myeloid Leukemia
May 5, 2020, Cancer Network
FDA Grants HQP1351 Orphan Drug Status in CML
May 4, 2020, OncLive
One-year-old's rare cancer treatment impacted by coronavirus (children with CML) (Urgent --- See Gofundme )
May 3, 2020, KUTV
Demystifying PCR-Based Molecular Monitoring in CML
May 1, 2020, ASH Clinical News
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a Case Report and Review of ABL Kinase Involvement in Viral Infection
May 1, 2020, Mediterranean Journal of Hematology and Infectious Diseases
Immune clues to help leukaemia patients safely stop treatment
MAY 1, 2020. Medical Xpress
Imatinib in COVID-19 disease in aged patients. (IMAGE-19)
May 1, 2020, ClinicalTrials.gov
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
May 1, 2020, Cell Metabolism
Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations
May 2020, Haematologica
Vaccination With Live Attenuated Vaccines in Four Children With Chronic Myeloid Leukemia While on Imatinib Treatment
April 2020, Frontiers in Immunology
Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells
April 2020, haematologica
Successful Treatment-Free Remission in Chronic Myeloid Leukaemia and Its Association With Reduced Immune Suppressors and Increased Natural Killer Cells
April 30, 2020, British Journal of Haematology
Sustained Molecular Response Following a Failed Attempt of Tyrosine Kinase Inhibitor Discontinuation & the Effects on Growth in a Child With Chronic Myeloid Leukemia: Not Always a Short Story
April 29, 2020, PubMed
The end of exponential growth: The decline in the spread of coronavirus
April 28, 2020, The Times of Israel
How to Prepare For a Virtual Visit With Your Oncologist
April 27, 2020, Patient Power
COVID-19 and CML: Frequently Asked Questions
April 27, 2020, Americam Society of Hematology
COVID-19 case collection and case discussion
April 27, 2020, iCMLf - International Chronic myeloid Foundation
Rare cancer a lonely experience
April 25, 2020, StAlbertToday
COVID-19 in persons with haematological cancers
April 24, 2020, Leukemia
Researchers Discover New Leukemia Genes Through CRISPR Technology
April 22, 2020, Interesting Engineering
How Many Chronic Myeloid Leukemia Patients Who Started a Frontline Second-Generation Tyrosine Kinase Inhibitor Have to Switch to a Second-Line Treatment? A Retrospective Analysis From the Monitoring Registries of the Italian Medicines Agency (AIFA)
April 22, 2020, PubMed
Early Switch to Dasatinib From First-Line Imatinib May Benefit Patients With Ph+ CML
April 21, 2020, Oncology Learning Network
CRISPR helps find new class of leukemia genes
April 21, 2020, Futurity
CML Research Aims to Improve a "Magic Bullet"
April 10, 2020, OncLive
DuBois woman donates stem cells to brother with Leukemia
April 20, 2020, Courier Express
Early Monitoring of Chronic Myeloid Leukemia Might Dictate TKI Switch
April 20, 2020, Cancer Therapy Advisor
Finding leukemia's weakness using genome-wide CRISPR technology
April 20, 2020, Science Daily
Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitors
April 17, 2020 , Sage Journals
Myeloid Blast Crisis of Chronic Myeloid Leukemia Followed by Lineage Switch to B-Lymphoblastic Leukemia: A Case Report
April 17, 2020, DovePress
A 106-year-old woman leaves UK hospital after recovering from coronavirus
April 16, 2020, CNN
Dr Reddy's Launches Generic Cancer Drug In India
April 15, 2020, CognitrexCancerDigest
Experts Establish Optimal Dosing of Nilotinib for Newly Diagnosed CML
April 14, 2020, Oncology Learning Network
Response and Resistance to BCR-ABL1-Targeted Therapies
April 13, 2020, Cancer Cell
Managing Treatment Toxicity in CML and MPNs
April 13, 2020, OncLive
Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
April 11, 2020, PubMed
CML Research Aims to Improve a "Magic Bullet"
April 10, 2020, OncLive
Staying Well-Nourished While Social Distancing
April 10, 2020, Leukemia & Lymphoma Society
Planned Phase III Trial of Ruxolitinib Plus Standard-of-Care for Patients with COVID-19
April 7, 2020, Cancer Network
Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study
April 7, 2020, PubMed
TKI Discontinuation in Patients With CML
April 7, 2020, Oncology Learning Network
OGT delivers translocation and partial tandem duplication detection with updates to SureSeq NGS portfolio
April 7, 2020, News Medical
CML Expert Discusses How to Protect Yourself From Coronavirus - Dr. Mauro
April 6, 2020, Patient Power
Food-effect study of nilotinib in chronic myeloid leukaemia (NiFo study): enabling dose reduction and relief of treatment burden
April 3, 2020, PubMed
COVID-19 & Hematology Information Center - EHA *** Must be seen ***
Recommendations for specific hematologic malignancies
March 2020, EHA
Coronavirus: Geoff Thomas gives isolation tips after cancer recovery
March 31, 2020, BBC News
Coronavirus Live Ask the Expert Webinars
March 30, 2020, Patient Power
TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries
March 30, 2020, PubMed
Roman Reigns Gets Involved With Blood Health Campaign
March 28, 2020, Wrestling Inc
How Patients with Cancer, and Survivors, Can Manage Stress Through COVID-19 Uncertainty
March 27, 2020, Cure
Canadian doctors urge caution on repurposing malaria medication to fight COVID-19
March 24, 2020, CBC
Successful Treatment of Chronic Myeloid Leukemia With Dasatinib After Kidney Transplantation: A Case Report
March 2020, Science Direct
Coronavirus: How eyes may play a role in its spread
March 2020, All about vision
Post-Transplant TKI Salvage Therapy Provides Significant Survival Benefit Following Relapse in CML
March 23, 2020, Oncology Learning Network
Coronavirus: 'I'm self-isolating - but I have 26 pen pals’ – Teenager with CML'
March 22, 2020, BBC News
CML Patient Shares Her Story to Provide Hope for Others VIDEO
March 11, 2020, Patient Power
The COVID Science Express: Ibuprofen Versus Acetaminophen
March 20, 2020, Mc Gill University
Common therapeutic vulnerability for a genetically diverse and deadly leukemia
March 18, 2020, Science Daily
COVID-19 Coronavirus Epidemic Has a Natural Origin
March 17, 2020, Science Daily
Coronavirus Spreads Quickly and Sometimes Before People Have Symptoms, Study Finds
March 17, 2020, Science Daily
COVID-19: The immune system can fight back
March 17, 2020, Science Daily
Researchers in Singapore find common therapeutic vulnerability for a genetically diverse and deadly leukaemia
March 17, 2020, Duke-Nus Medical School
10 Positive Updates on the COVID-19 Outbreaks From Around the World
March 17, 2020, Good News Network
Researchers in Singapore find common therapeutic vulnerability for a genetically diverse and deadly leukaemia
March 17, 2020, DUKE NUS Medical School
First Person Injected With Trial Coronavirus Vaccine In Seattle
March 17, 2020, Forbes
Coronavirus: what it means for your travel insurance
March 16, 2020, Which?
Spanish coach Francisco Garcia, 21, dies after coronavirus diagnosis
March 16, 2020, ESPN
Francisco Garcia death: Spanish football coach dies from coronavirus aged 21
March 16, 2020, Independent
Treatments for Chronic Myeloid Leukemia can sometimes fail, but there is hope
Mar 13, 2020, Day-Times Tri-Cities
Switching to Nilotinib After Frontline Imatinib Feasible, Effective for Chronic Phase CML
Mar 13, 2020, Oncology Learning Network
Commentary: Can vitamin C really help with your cold or even COVID-19?
March 12, 2020, Channel News Asia
Do Patients With Cancer Need Disease-Specific Precautions to Prevent COVID-19 Infection?
March 12, 2020, Cancer Therapy Advisor
An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia
March 10, 2020, Journal Blood
Advice on coronavirus for people affected by blood cancer VIDEO
March 10, 2020, dwise
